September 2023 Norton Medical Group new providers

Paul A. Adams, M.D. Emergency Medicine Matthew P. Allinder, M.D. Emergency Medicine Austin C. Baker, M.D. Emergency Medicine Jared S. Bass, D.O. Emergency Medicine Shannon M. Becht, M.D. Emergency Medicine Kristen Bublitz, D.O. Emergency Medicine […]

Shawn W. Adams, M.D., joins Norton Leatherman Spine

Tzield may delay Stage 3 Type 1 diabetes in adults and children

Recently approved Tzield (teplizumab-mzwv), is delivering breakthrough results that suggest it may delay the onset of Stage 3 Type 1 diabetes by an average of two years. The first-in-class drug is approved for adults and […]

Ultra-fast-acting inhaled insulin, Afrezza, trialed at Norton Children’s Endocrinology

Afrezza inhaled insulin, currently approved for adults, is being tested for children in a clinical trial at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine. Norton […]

DFMO medulloblastoma clinical trial examines drug’s effectiveness for high-risk cases

Butyrate-producing gut bacteria a promising avenue for Alzheimer’s treatment

Butyrate-producing gut bacteria are a promising target for preventing and treating memory loss associated with Alzheimer’s disease, according to research presented recently at the Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands. The research in […]